These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21788357)

  • 21. A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas.
    Raizer JJ; Grimm S; Chamberlain MC; Nicholas MK; Chandler JP; Muro K; Dubner S; Rademaker AW; Renfrow J; Bredel M
    Cancer; 2010 Nov; 116(22):5297-305. PubMed ID: 20665891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo.
    Bello L; Carrabba G; Giussani C; Lucini V; Cerutti F; Scaglione F; Landré J; Pluderi M; Tomei G; Villani R; Carroll RS; Black PM; Bikfalvi A
    Cancer Res; 2001 Oct; 61(20):7501-6. PubMed ID: 11606386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early perfusion changes in patients with recurrent high-grade brain tumor treated with Bevacizumab: preliminary results by a quantitative evaluation.
    Vidiri A; Pace A; Fabi A; Maschio M; Latagliata GM; Anelli V; Piludu F; Carapella CM; Giovinazzo G; Marzi S
    J Exp Clin Cancer Res; 2012 Apr; 31(1):33. PubMed ID: 22494770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo therapy of local tumor progression by targeting vascular endothelium with EMAP-II.
    Schwarz RE; Schwarz MA
    J Surg Res; 2004 Jul; 120(1):64-72. PubMed ID: 15172191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.
    Castro BA; Flanigan P; Jahangiri A; Hoffman D; Chen W; Kuang R; De Lay M; Yagnik G; Wagner JR; Mascharak S; Sidorov M; Shrivastav S; Kohanbash G; Okada H; Aghi MK
    Oncogene; 2017 Jun; 36(26):3749-3759. PubMed ID: 28218903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts.
    Perry MC; Demeule M; Régina A; Moumdjian R; Béliveau R
    Mol Nutr Food Res; 2010 Aug; 54(8):1192-201. PubMed ID: 20087857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal brain imaging of five malignant glioma patients treated with bevacizumab using susceptibility-weighted magnetic resonance imaging at 7 T.
    Grabner G; Nöbauer I; Elandt K; Kronnerwetter C; Woehrer A; Marosi C; Prayer D; Trattnig S; Preusser M
    Magn Reson Imaging; 2012 Jan; 30(1):139-47. PubMed ID: 21982163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local intracerebral delivery of endogenous inhibitors by osmotic minipumps effectively suppresses glioma growth in vivo.
    Giussani C; Carrabba G; Pluderi M; Lucini V; Pannacci M; Caronzolo D; Costa F; Minotti M; Tomei G; Villani R; Carroll RS; Bikfalvi A; Bello L
    Cancer Res; 2003 May; 63(10):2499-505. PubMed ID: 12750272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model.
    Mathieu V; De Nève N; Le Mercier M; Dewelle J; Gaussin JF; Dehoux M; Kiss R; Lefranc F
    Neoplasia; 2008 Dec; 10(12):1383-92. PubMed ID: 19048117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells.
    Hui AM; Zhang W; Chen W; Xi D; Purow B; Friedman GC; Fine HA
    Cancer Res; 2004 Dec; 64(24):9115-23. PubMed ID: 15604281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of bevacizumab on angiogenesis and growth of canine osteosarcoma cells xenografted in athymic mice.
    Scharf VF; Farese JP; Coomer AR; Milner RJ; Taylor DP; Salute ME; Chang MN; Neal D; Siemann DW
    Am J Vet Res; 2013 May; 74(5):771-8. PubMed ID: 23627391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas.
    Chamberlain MC
    Cancer; 2010 Sep; 116(17):3988-99. PubMed ID: 20564141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Change in pattern of relapse after antiangiogenic therapy in high-grade glioma.
    Narayana A; Kunnakkat SD; Medabalmi P; Golfinos J; Parker E; Knopp E; Zagzag D; Eagan P; Gruber D; Gruber ML
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):77-82. PubMed ID: 21163583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophils promote the malignant glioma phenotype through S100A4.
    Liang J; Piao Y; Holmes L; Fuller GN; Henry V; Tiao N; de Groot JF
    Clin Cancer Res; 2014 Jan; 20(1):187-98. PubMed ID: 24240114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo.
    Tsai NM; Lin SZ; Lee CC; Chen SP; Su HC; Chang WL; Harn HJ
    Clin Cancer Res; 2005 May; 11(9):3475-84. PubMed ID: 15867250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-regulatory factor-1 (IRF1) regulates bevacizumab induced autophagy.
    Liang J; Piao Y; Henry V; Tiao N; de Groot JF
    Oncotarget; 2015 Oct; 6(31):31479-92. PubMed ID: 26362401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma.
    Riina HA; Fraser JF; Fralin S; Knopman J; Scheff RJ; Boockvar JA
    J Exp Ther Oncol; 2009; 8(2):145-50. PubMed ID: 20192120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour control by whole brain irradiation of anti-VEGF-treated mice bearing intracerebral glioma.
    Verhoeff JJ; Stalpers LJ; Claes A; Hovinga KE; Musters GD; Peter Vandertop W; Richel DJ; Leenders WP; van Furth WR
    Eur J Cancer; 2009 Nov; 45(17):3074-80. PubMed ID: 19734041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.